null

SMILES: COc1cc(OC)c(Cl)c(c1Cl)-c1cc2cnc(N[C@@H]3CCC[C@@H]3NC(=O)C=C)nc2n(C)c1=O

InChI Key:

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50561591   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Fibroblast growth factor receptor 2 (Homo sapiens (Human))	BDBM50561591 (CHEMBL4793510) Show SMILES COc1cc(OC)c(Cl)c(c1Cl)-c1cc2cnc(N[C@@H]3CCC[C@@H]3NC(=O)C=C)nc2n(C)c1=O |r,wU:19.19,23.25,(19.41,-17.19,;18.08,-17.97,;18.08,-19.51,;19.42,-20.27,;19.43,-21.82,;20.76,-22.6,;20.77,-24.14,;18.09,-22.6,;18.09,-24.14,;16.75,-21.82,;16.75,-20.28,;15.42,-19.51,;15.42,-22.59,;14.09,-21.81,;12.77,-22.59,;11.45,-21.8,;10.11,-22.56,;10.1,-24.1,;8.76,-24.86,;7.43,-24.09,;7.28,-22.55,;5.77,-22.22,;5,-23.55,;6.02,-24.7,;5.69,-26.21,;4.22,-26.67,;3.08,-25.64,;3.89,-28.18,;2.42,-28.65,;11.42,-24.87,;12.75,-24.12,;14.09,-24.89,;14.08,-26.43,;15.43,-24.13,;16.76,-24.9,)| Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	247	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Inhibition of recombinant human tagged FGFR2 using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method				Citation and Details Article DOI: 10.1021/acsmedchemlett.9b00601 BindingDB Entry DOI: 10.7270/Q2CN77NN
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 2 (Homo sapiens (Human))	BDBM50561591 (CHEMBL4793510) Show SMILES COc1cc(OC)c(Cl)c(c1Cl)-c1cc2cnc(N[C@@H]3CCC[C@@H]3NC(=O)C=C)nc2n(C)c1=O |r,wU:19.19,23.25,(19.41,-17.19,;18.08,-17.97,;18.08,-19.51,;19.42,-20.27,;19.43,-21.82,;20.76,-22.6,;20.77,-24.14,;18.09,-22.6,;18.09,-24.14,;16.75,-21.82,;16.75,-20.28,;15.42,-19.51,;15.42,-22.59,;14.09,-21.81,;12.77,-22.59,;11.45,-21.8,;10.11,-22.56,;10.1,-24.1,;8.76,-24.86,;7.43,-24.09,;7.28,-22.55,;5.77,-22.22,;5,-23.55,;6.02,-24.7,;5.69,-26.21,;4.22,-26.67,;3.08,-25.64,;3.89,-28.18,;2.42,-28.65,;11.42,-24.87,;12.75,-24.12,;14.09,-24.89,;14.08,-26.43,;15.43,-24.13,;16.76,-24.9,)| Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	359	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Inhibition of FGFR2 (unknown origin) expressed in KATO -III cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discove...				Citation and Details Article DOI: 10.1021/acsmedchemlett.9b00601 BindingDB Entry DOI: 10.7270/Q2CN77NN
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM50561591 (CHEMBL4793510) Show SMILES COc1cc(OC)c(Cl)c(c1Cl)-c1cc2cnc(N[C@@H]3CCC[C@@H]3NC(=O)C=C)nc2n(C)c1=O |r,wU:19.19,23.25,(19.41,-17.19,;18.08,-17.97,;18.08,-19.51,;19.42,-20.27,;19.43,-21.82,;20.76,-22.6,;20.77,-24.14,;18.09,-22.6,;18.09,-24.14,;16.75,-21.82,;16.75,-20.28,;15.42,-19.51,;15.42,-22.59,;14.09,-21.81,;12.77,-22.59,;11.45,-21.8,;10.11,-22.56,;10.1,-24.1,;8.76,-24.86,;7.43,-24.09,;7.28,-22.55,;5.77,-22.22,;5,-23.55,;6.02,-24.7,;5.69,-26.21,;4.22,-26.67,;3.08,-25.64,;3.89,-28.18,;2.42,-28.65,;11.42,-24.87,;12.75,-24.12,;14.09,-24.89,;14.08,-26.43,;15.43,-24.13,;16.76,-24.9,)| Show InChI	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	35	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Inhibition of FGFR4 (unknown origin) expressed in human Huh7 cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discov...				Citation and Details Article DOI: 10.1021/acsmedchemlett.9b00601 BindingDB Entry DOI: 10.7270/Q2CN77NN
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 4 (Homo sapiens (Human))	BDBM50561591 (CHEMBL4793510) Show SMILES COc1cc(OC)c(Cl)c(c1Cl)-c1cc2cnc(N[C@@H]3CCC[C@@H]3NC(=O)C=C)nc2n(C)c1=O |r,wU:19.19,23.25,(19.41,-17.19,;18.08,-17.97,;18.08,-19.51,;19.42,-20.27,;19.43,-21.82,;20.76,-22.6,;20.77,-24.14,;18.09,-22.6,;18.09,-24.14,;16.75,-21.82,;16.75,-20.28,;15.42,-19.51,;15.42,-22.59,;14.09,-21.81,;12.77,-22.59,;11.45,-21.8,;10.11,-22.56,;10.1,-24.1,;8.76,-24.86,;7.43,-24.09,;7.28,-22.55,;5.77,-22.22,;5,-23.55,;6.02,-24.7,;5.69,-26.21,;4.22,-26.67,;3.08,-25.64,;3.89,-28.18,;2.42,-28.65,;11.42,-24.87,;12.75,-24.12,;14.09,-24.89,;14.08,-26.43,;15.43,-24.13,;16.76,-24.9,)| Show InChI	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	73	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Inhibition of recombinant human wild type N-His tagged FGFR4 (460-802) using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method				Citation and Details Article DOI: 10.1021/acsmedchemlett.9b00601 BindingDB Entry DOI: 10.7270/Q2CN77NN
					More data for this Ligand-Target Pair